Home > Back to Publisher > Report Information

Bioterrorism Defense Markets - Assessment of Opportunities And Security Threats

Planned Business Reports
September 1, 2003
88 Pages - SKU: BBEQ1324982

Abstract Table of Contents Search inside this report Related Reports

This independent, objective and reliable research report-based on primary interviews with equipment suppliers and consultants provides the accurate and timely information you need to create and implement effective, successful market strategies.

WITHIN THIS REPORT YOU WILL FIND INFORMATION HELPFUL IN:

Market sizing by product type and application
Developing Marketing Strategies
Assessing End-User Needs
Finding New Markets
Approaching New Channels of Distribution
Analyzing the Competition
Creating Forecast Models Based on Market Trends
Preparing Internal Market Research Reports and

WHO SHOULD USE THIS REPORT:

Suppliers of Bioterrorism Defense Equipment
Clinical Laboratories and Institutes
Senior Marketing & Sales Management
Internal Research Departments
Investment Bankers
Venture Capitalists
Distributors
Manufacturers Representatives
Government Agencies

SCOPE OF COVERAGE:

Bioterrorism products and services markets size and growth rates between 2003 and 2008
Bioterrorism’s history--who poses a threat, why the threat is growing, bioterrorism agents, agents of the highest concern, government agencies involved, types of response, and FAQs for a biological attack
An analysis of the Department of Homeland Security, the U.S. government agency leading the charge against bioterrorism
What the Department of Health and Human Services is doing in the fight on bioterrorism
Who are first responders and what role do they play in fighting bioterrorism
What is the best strategy for biodefense
What are the latest products and projects in biodetection technology, and how big is the market by application for biodetection technology
How big is the market by product type for civilian and military bioterrorism respirators and protective clothing?
What role do vaccines and antibodies play in the war on bioterrorism, and how big is the market for smallpox and anthrax vaccines and antibodies now and in the future.

INTRODUCTION: Background and Scope of the Report; Methodology and Sources Statistical Notes
A. MARKET OVERVIEW Producers: Retailers; Retail fraud
B. BIOTERRORISM: AN OVERVIEW: Definitions; History of Biological Warfare; Biological Warfare Agreements; Who Poses a Threat—Biological Warfare Programs; The Growing Threat; Potential Bioterrorism Agents; Biological Agents of Highest Concern; Advantages of Biologics as Weapons; Bioterrorism and the Food Supply; Bioterrorism Threats Reported to FBI; Federal Agencies Involved in Bioterrorism; Bioterrorism Agent Transmission; How Long Do We Have If Attacked?; Who are First Responders?; Medical Response to Bioterrorism; Public Health Response to Bioterrorism; Laboratory Response Network for Bioterrorism; What To Do in a Biological Attack; FAQs for a Biological Attack
C. DEPARTMENT OF HOMELAND SECURITY: Department of Homeland Security Budget; Threats and Protection: Homeland Security Advisory System; Problems with Homeland Security Advisory System
D. DEPARTMENT OF HEALTH AND HUMAN SERVICES
E. FIRST RESPONDERS
F. BIODEFENSE: U.S. Government Biodefense Projects
G. BIOTERRORISM DETECTORS: Biodetection Overview; Technology; Standards; U.S. Postal Service Bioterrorism Attack Detection; U.S. Government EPA Bioterrorism Attack Detection; BASIS; APDS; HANAA; Department of Defense Detection Systems; New Detection Systems; Market for Biodetectors; Biodetector Companies
H. RESPIRATOR PROTECTIVE EQUIPMENT: Respiratory Protection; Respiratory Market; Company Profiles
I. PERSONAL PROTECTIVE CLOTHING: Protective Clothing; Clothing Market; Company Profile
J. VACCINES AND ANTIBODIES FOR BIOTERRORISM: Smallpox; Smallpox Market; Anthrax; Anthrax Market; Product Development Issues; Other
LIST OF TABLES: Table 1 U.S. Bioterrorism Defense Market: 2003-2008; Table 2 Bioterrorism Defense Company Sales: 2003; Table 3 Biological Attacks: Threats, Immediate Action, Symptoms, Treatment if Exposed; Table 4 U.S. Department of Homeland Security Budget Authority by Funding Account: 2002-2004; Table 5 U.S. Department of Homeland Security Budget Authority for Border and Transportation Security by Funding Account: 2002-2004; Table 6 U.S. Department of Homeland Security Budget Authority for the Coast Guard by Funding Account: 2002-2004; Table 7 U.S. Department of Homeland Security Budget Authority for Emergency Preparedness and Response by Funding Account: 2002-2004; Table 8 U.S. Department of Homeland Security Budget Authority for Information Analysis and Infrastructure Protection: 2002-2004; Table 9 U.S. Department of Homeland Security Budget Authority for Science & Technology: 2002-2004; Table 10 U.S. Department of Homeland Security Budget Authority for Citizen & Immigration Services: 2002-2004; Table 11 U.S. Department of Homeland Security Budget Authority for the Secret Service: 2002-2004; Table 12 U.S. Department of Homeland Security Budget Authority for the Office of Inspector General: 2002-2004; Table 13 U.S. Department of Homeland Security Budget Authority for Department-Wide Support: 2002-2004; Table 14 U.S. Department of HHS Bioterrorism Funding: 2002-2004; Table 15 Council on Foreign Relations First Responder Unmet Budget Needs Estimate: 2004-2008; Table 16 Police Officers, Sheriffs, Fire Fighters & EMS by State: 2002; Table 17 Fire Department & EMS Specialization by Type: 2002; Table 18 U.S. Public Safety Departments by Type: 2002; Table 19 U.S. First Responder Physicians’ Specialization by Type: 2003; Table 20 Methods of Biodetection; Table 21 U.S. Biodetector Market by Application: 2003-2008; Table 22 U.S. Market for Respirators Used in Bioterrorism Applications by Type: 2003-2008; Table 23 U.S. Suppliers of Respirators Used in Bioterrorism Applications - Sales & Market Shares: 2003; Table 24 U.S. Market for Protective Clothing Used in Bioterrorism Applications by Type: 2003-2008; Table 25 U.S. Suppliers of Protective Clothing Used in Bioterrorism Applications - Sales & Market Shares: 2003; Table 26 Acambis Smallpox Vaccine Sales Value, Volume, ASP: 2003-2008; Table 27 Anthrax Antibody and Vaccine Sales Value, Volume, ASP: 2003-2008

Bioterrorism Defense Markets - Assessment of Opportunities And Security Threats

Share this report

Other tasks

Research Assistance

Related Markets

Defense Reports

Free Alert Me service